Keyphrases
Atherosclerotic Risk Factors
9%
Atrial Fibrillation Treatment
9%
Atrial Pacemaker
9%
Beta-blockers
9%
Black Race
9%
Body Mass Index
9%
Cardiovascular Disease
9%
Cardiovascular Health Study
9%
Cardiovascular Risk
9%
Clinical Modification
9%
Confidence Interval
18%
Cystatin C (Cys C)
9%
Epidemiology
9%
Hazard Ratio
18%
Heart Rate
9%
Hospital Discharge
9%
Hypertension
9%
International Classification of Diseases
9%
Low Heart Rate
9%
Low Risk
18%
Medical Record Review
9%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
9%
Pacemaker Implantation
9%
Pacemaker Therapy
9%
People of Color
18%
Population Aging
9%
QRS Interval
9%
Right Bundle Branch Block
9%
Risk Factors
100%
Sick Sinus Syndrome
100%
United States
9%
White People
18%
White Race
9%
Medicine and Dentistry
Amino Terminal Sequence
9%
Atherosclerosis
9%
Atrial Fibrillation
9%
Beta Adrenergic Receptor Blocking Agent
9%
Body Mass Index
9%
Brain Natriuretic Peptide
9%
Cardiovascular Disease
9%
Cardiovascular Risk
9%
Cardiovascular System
9%
Cohort Effect
9%
Cystatin C
9%
Hazard Ratio
18%
International Classification of Diseases
9%
Medical Record
9%
Pacemaker Implantation
9%
QRS Interval
9%
Right Bundle Branch Block
9%
Sick Sinus Syndrome
100%
Pharmacology, Toxicology and Pharmaceutical Science
Atherosclerosis
9%
Atrial Fibrillation
9%
Beta Adrenergic Receptor Blocking Agent
9%
Brain Natriuretic Peptide
9%
Cardiovascular Disease
9%
Cardiovascular Risk
9%
Cystatin C
9%
Heart Right Bundle Branch Block
9%
International Classification of Diseases
9%
Sick Sinus Syndrome
100%